Evidence map›Paper›PMID 42011256›Full record

ArticleJournal of pharmaceutical analysis2026

A novel high-entropy TiVCrMoC

Zhilong Chu, Xi Yu, Xiao Wang, Wenqiang Zhang, Yuming Li, Xinfeng Yan, Weining Yan, Hongzheng Meng, Lingyu Li, Guanhua Zhang and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmaceutical analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhilong ChuThe First Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Jinan, 250014, China.
Xi YuThe First Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Jinan, 250014, China.
Xiao WangShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014, China.
Wenqiang ZhangThe First Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Jinan, 250014, China.
Yuming LiFirst Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Xinfeng YanThe First Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Jinan, 250014, China.
Weining YanShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250022, China.
Hongzheng MengThe First Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Jinan, 250014, China.
Lingyu LiShandong Agricultural University, Tai'an, Shandong, 271018, China.
Guanhua ZhangChina Academy of Chinese Medical Sciences, Beijing, 100700, China.
Ruya WangJilin University School of Pharmaceutical Sciences, Changchun, 130021, China.
Miaomiao LiShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014, China.
Jun LiShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014, China.
Weiqiang LiangThe First Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Jinan, 250014, China.
Chunxia MaShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Worldwide, rheumatoid diseases account for approximately 37.57/100,000 disability-adjusted life years (DALYs). Early diagnosis of rheumatoid arthritis (RA) can effectively reduce associated risks and improve quality of life. To achieve this, accurate and rapid advanced tools are required. Herein, TiVCrMoC

Indexed as

Machine learningRheumatoid arthritisSALDI-MSSerum metabolic fingerprintTiVCrMoC3

Identifiers

PMID42011256
PMCPMC13092000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.